These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31516591)

  • 1. nm23, TOP2A and VEGF expression: Potential prognostic biologic factors in peripheral T-cell lymphoma, not otherwise specified.
    Huang W; Cao Z; Zeng L; Guo L; Liu X; Lv N; Feng X
    Oncol Lett; 2019 Oct; 18(4):3803-3810. PubMed ID: 31516591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological type distribution and expression of nm23, VEGF, TOP2A and MUM-1 in peripheral T-cell and NK-cell lymphomas in Chinese: analysis of 313 cases.
    Huang W; Ma W; Qiu T; Shan L; Zeng L; Guo L; Ying J; Lv N; Feng X
    Int J Clin Exp Pathol; 2018; 11(10):5086-5093. PubMed ID: 31949586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
    Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
    Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
    Niitsu N
    J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified.
    Zhang W; Wang L; Zhou D; Cui Q; Zhao D; Wu Y
    Leuk Lymphoma; 2011 Jan; 52(1):46-52. PubMed ID: 21077742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified.
    Niitsu N; Nakamine H; Okamoto M
    Clin Cancer Res; 2011 May; 17(9):2893-9. PubMed ID: 21478336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of vascular endothelial growth factor and nm23 as prognostic factors in nasopharyngeal carcinoma].
    Zhang G; Zeng J; Gong L; Wu G; Zhou Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):372-5. PubMed ID: 12761948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
    Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
    Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.
    Tolkachjov SN; Weenig RH; Comfere NI
    J Am Acad Dermatol; 2016 Nov; 75(5):992-999. PubMed ID: 27498959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
    Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
    Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
    J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified.
    Kim HD; Cho H; Sohn BS; Park CS; Huh J; Ryu JS; Lee SW; Yoon SE; Kim SJ; Ko YH; Kim WS; Suh C
    Leuk Lymphoma; 2022 Jan; 63(1):124-130. PubMed ID: 34702115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
    Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
    Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
    Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
    Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological analysis in PTCL-NOS with CADM1 expression.
    Kato T; Miyoshi H; Kobayashi S; Yoshida N; Imaizumi Y; Seto M; Uchimaru K; Miyazaki Y; Ohshima K
    Virchows Arch; 2017 Nov; 471(5):659-666. PubMed ID: 28940014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.